Abstract-Objectives: 1) To determine the regional pattern of reduced N-acetylaspartate (NAA) in subcortical ischemic vascular dementia (SIVD); 2) to explore the relationship between NAA reduction and subcortical vascular disease; and 3) to test if MR spectroscopic imaging (MRSI) in combination with structural MRI improves differentiation between SIVD and Alzheimer disease (AD). Methods: Thirteen patients with SIVD (71 Ϯ 8 years old) and 43 patients with AD of comparable age and dementia severity were studied using MRSI and MRI. Patients were compared to 52 cognitively normal subjects with and without lacunes. Results: Compared to controls, patients with SIVD had lower NAA by 18% (p Ͻ 0.001) in frontal cortex and by 27% (p Ͻ 0.003) in parietal cortex, but no significant NAA reduction in white matter and medial temporal lobe. Compared to patients with AD, patients with SIVD had lower NAA by 13% (p Ͻ 0.02) in frontal cortex and by 20% (p Ͻ 0.002) in left parietal cortex. Cortical NAA decreased in SIVD with increasing white matter lesions (r ϭ 0.54, p Ͻ 0.02) and number of lacunes (r ϭ 0.59, p Ͻ 0.02). Thalamic lacunes were associated with greater NAA reduction in frontal cortex than were lacunes outside the thalamus (p Ͻ 0.02) across groups, after adjusting for cognitive impairments. Adding parietal NAA to MRI-derived hippocampal atrophy improved separation between SIVD and AD (p ϭ 0.02) from 79 to 89%. Conclusions: These results emphasize the importance of cortical dysfunction as a factor in SIVD and indicate a characteristic pattern of metabolite change that might serve as a basis for improved diagnosis. NEUROLOGY 2003;61:358 -364 The contribution of subcortical ischemic vascular disease (SIVD) to cognitive impairment and dementia is poorly understood. Disruption of subcortical-cortical connections by strategically located infarctions is considered one important mechanism for cognitive impairment in SIVD.
The contribution of subcortical ischemic vascular disease (SIVD) to cognitive impairment and dementia is poorly understood. Disruption of subcortical-cortical connections by strategically located infarctions is considered one important mechanism for cognitive impairment in SIVD. 1 MRI studies from our group found that cognitive deficits in patients with SIVD were strongly correlated with brain atrophy, whereas subcortical infarctions made little contributions. 2, 3 Aside from greater numbers of ischemic lesions and more extensive white matter hyperintensities (WMH), other MRI studies comparing SIVD and Alzheimer disease (AD) have shown atrophy in the hippocampus and entorhinal cortex in both dementias, although less prominent in SIVD than in AD. 4, 5 Furthermore, some patients with SIVD without AD pathology confirmed by autopsy had reduced hippocampal and cortical gray matter volumes. 2 Therefore, MRI has limited ability to differentiate between SIVD and AD.
In vivo proton magnetic resonance spectroscopic imaging ( 1 H MRSI) can measure the regional distribution of N-acetylaspartate (NAA) in the brain. Because NAA is present at high concentration only in living neurons and is virtually undetectable in other cell types, such as glia, 6 it is thought to be an indicator of neuronal density and neuronal metabolism. 7 In AD, a 1 H MRSI study found the most prominent NAA losses in parietal gray matter and in the hippocampus, but not in white matter. 8 However, regional differences in NAA reductions between SIVD and AD have not been investigated thoroughly.
Therefore, the first aim of this study was to determine the regional pattern of NAA in gray matter, white matter, and WMH in SIVD. We hypothesized that SIVD would be associated with a different regional pattern of diminished NAA concentration than AD, because neuronal damage in SIVD would be related to subcortical vascular disease. The second aim of the study was to examine the relationship between subcortical vascular disease and cortical NAA reduction. Specifically, we predicted that NAA reduction in the frontal cortex would be associated with thalamic lacunes, because a large number of connections from thalamic nuclei project generally to zones in the frontal cortex. 9, 10 The third aim of this study was to test whether NAA measurements when added to MRI measurements of brain volumes improve discrimination between patients with SIVD and AD and control subjects. 29 .0 Ϯ 0.8). ADϩL and AD-L patients in this study were selected from a larger patient group to match dementia severity and age range of the patients with SIVD. Similarly, CNϩL and CN-L subjects were chosen from a cognitively normal cohort to match approximately the age distribution of patients. MRSI data of AD-L and CN-L subjects have been reported in part earlier. 8 Patients with SIVD and AD were recruited from the Memory and Aging Clinic of the University of California at San Francisco (UCSF) and the Alzheimer Center of the University of California at Davis (UCD). The CN subjects were recruited from the community and received standard neurologic examinations at the same centers. CN subjects had cognitive test scores within the normal, ageadjusted range and no clinical history of alcoholism, psychiatric illness, epilepsy, hypertension, diabetes, major heart disease, or head trauma. Furthermore, a neuroradiologist evaluated the MRI data of all subjects for subcortical lacunar infarcts and, if present, counted their number by anatomic region. The definition of lacunar infarcts was based on original work by Fisher, 14 combined with current clinical concepts. Evaluation was performed using axial proton density-weighted and coronal T1-weighted MR images. Focal areas of increased signal intensity in subcortical gray and white matter on proton density-weighted MRI measuring 5 to 15 mm in diameter were characterized as lacunes. The intensity on T1-weighted MRI may be variable. All areas of increased signal intensity on proton density MRI in the corona radiata and centrum semiovale were characterized as WMH, unless they exhibited discrete low intensity on T1-weighted MRI with a diameter range of 5 to 15 mm, in which case they were characterized as lacunes. All lesions complied with expected perforating vessel distribution.
Eleven patients (all AD) reported taking cholinesterase inhibitors and four patients (3 AD, 1 SIVD) anticholinergic drugs; two patients had incomplete records of medication. Medication information was collected at annual clinical visits, which were close to the time of MRI. Furthermore, one patient with SIVD and four patients with AD were given sedative (lorazepam 1 mg) to relax during MR scans. The committees of human research at UCSF, UCD, and the Veterans Affairs Medical Center in San Francisco approved the study, and written informed consent was obtained from each subject or a legal guardian before participation.
MRI and 1 H MRSI acquisition and processing. Data acquisition and processing have been described in detail. 15 In brief, MRI and 1 H MRSI data were obtained in one session on a 1.5 T Siemens Vision System (Siemens Inc., Iselin, NJ). The protocol for structural MRI included axially oblique double spin echo (DSE) images with repetition time (TR)/echo time (TE)1/TE2 ϭ 2500/ 20/80 msec, 1.0 ϫ 1.4 mm 2 inplane resolution, and 3-mm-thick sections with no section gap. In addition, volumetric magnetization-prepared rapid gradient echo (MPRAGE) images were acquired with TR/TE/inversion time (TI) ϭ 10/7/300 msec, 15°flip angle, 1.0 ϫ 1.0 mm 2 inplane resolution, and 1.4-mm-thick coronal partitions, oriented approximately orthogonal to the long axis of the hippocampus. Proton density and T2-weighted images from DSE and T1-weighted images from MPRAGE were used together for tissue segmentation and T1-weighted images from MPRAGE were used for manual tracing of the hippocampus. The 1 H MRSI protocol included a point resolved spectroscopy (PRESS) 1 Volumes of left and right hippocampus were measured by drawing the boundaries manually on coronal T1-weighted MR images. 17 Tissue segmentation of MRI data into gray matter, white matter, and CSF was achieved automatically with software developed inhouse. 18 Additional operator-assisted segmentation classified gray matter into cortical gray matter and subcortical gray matter and white matter into normal-appearing white matter and WMH. Furthermore, the interhemispheric fissure and the central sulcus were marked on MR images to determine the boundaries between the right and left cerebral hemispheres and frontal and parietal lobes for coanalysis with MRSI. Finally, the masks of the left and right hippocampus from manual tracing were also incorporated into the segmentation data. The raters were blinded to all clinical information. Consistency of manual ratings (expressed as a coefficient of variation) was about 1.0% for hippocampus and better than 2% for tissue segmentation.
Spectral processing and MRI-MRSI coanalysis. After Fourier transformation of 1 H MRSI, the peak areas of NAA, creatine (Cr), and choline (Cho) containing compounds were estimated using fully automated spectral fitting software developed inhouse. 19 Metabolite concentrations (denoted [NAA], [Cho] , and [Cr]) were obtained separately for gray matter and white matter of the left and right, frontal and parietal lobes, first by estimating the tissue composition of each MRSI voxel based on segmented MRI data coregistered to MRSI, and second by regressing metabolite intensities against tissue composition of MRI voxels. This allowed estimation of metabolite concentrations of "pure" gray matter and white matter. 15 Spurious signal contributions from neighboring regions, such as subcortical gray matter or occipital lobe, were accounted for by screening out voxels from these regions. Similarly, metabolite concentrations of hippocampus and WMH were determined by selecting MRSI voxels, which contained mainly hippocampal or WMH tissue, and by correcting for partial volumes of CSF. 20 Because metabolite signals were not corrected for T1 and T2 relaxation, concentrations in this study were expressed in arbitrary units rather than in millimoles/liter. In analyzing MRSI data, two patients with SIVD and three patients with AD had corrupt multislice MRSI data, mainly because of movements between MRI and MRSI acquisitions, and were therefore not included in analyses that involved frontal and parietal lobes. PRESS MRSI data from all subjects had acceptable quality and no exclusions were necessary in analyses that involved medial temporal lobe.
Statistical analysis. Effects of diagnosis on regional variations of metabolite concentrations were tested using multivariate analysis of variance (MANOVA), followed by post hoc univariate ANOVA tests to determine differences between groups. The dependent variables were metabolite concentrations and the independent variables were regions and diagnosis. Age and sex were added as covariate when appropriate. To reduce the probability of finding regional effects on metabolites by chance, the level of significance was raised to ␣ ϭ 0.05/3 Ϸ 0.02 (based on three independent tests for gray matter, white matter, and hippocampus), implementing Bonferroni correction for multiple comparisons. Tests for WMH were not counted as multiple comparisons, because they did not involve regions. To enable comparisons between PRESS and multislice MRSI data irrespectively of experimental differences, metabolite concentrations obtained with each method were transformed into z-scores, according to zM r ϭ (M r Ϫ mean(M r CN ))/stdev(M r CN ). Here, zM r represents a patient's z-score of metabolite M in a brain region r (r ϭ hippocampus, frontal or parietal, left or right gray matter or white matter and mean(M r CN )
are mean values and stdev(M r CN ) standard deviations in each brain region in CN subjects. Classification of AD, SIVD, and CN subjects based on MRI and MRSI was tested using logistic regressions with MRI and MRSI measures predicting diagnosis. Furthermore, receiver operator characteristics (ROC) analysis was performed to provide a means of comparing MRI and MRSI classifiers in terms of sensitivity and specificity. Group values are listed as means and standard deviations, unless otherwise noted.
Results. Table 1 lists the demographic data of the subjects as well as the load of cerebrovascular disease in each group, evaluated by WMH and number of lacunes. Patients with SIVD were not markedly younger than the other groups (F ϭ 2.2, df ϭ 4,103, p Ͻ 0.08). MMSE scores of patients were comparable between AD and SIVD (F ϭ 0.02, df ϭ 2,53, p Ͼ 0.9), but substantially lower than the scores of CN subjects (F ϭ 147, df ϭ 1,106, p Ͻ 0.001), as expected. CN subjects with and without lacunes did not differ with respect to MMSE scores (F ϭ 0.2, df ϭ 1,50, p Ͼ 0.6). Sex was reasonably balanced in the AD and CN groups (all p Ͼ 0.5 by 2 tests), but women were underrepresented in the SIVD group (p ϭ 0.03).
In analyzing MRSI, we first determined whether metabolite differences between ADϩL and AD-L patients and between CNϩL and CN-L subjects needed to be considered. MANOVA tests indicated that there were no differences in MRSI data between ADϩL and AD-L (p Ͼ 0.5) and between CNϩL and CN-L (p Ͼ 0.9). Therefore, comparisons between SIVD and the other groups were performed without differentiating between individuals with and without lacunes. 
Figure 1. Relationship between cortical [NAA] and subcortical vascular disease, assessed by white matter hyperintensities (WMH) and number of lacunes in patients with subcortical ischemic vascular disease (F) and cognitively normal subjects (⅜). WMH volume was indexed to percent of normal white matter and [NAA] is represented in arbitrary units (au).
correlations between cortical [NAA] and lacunes were not tested for AD. To explore further the idea that lacunar infarctions in strategic subcortical regions induce damage to remote cortical neurons, we tested whether [NAA] loss in the frontal cortex would be related to thalamic lacunes. This analysis was performed with data from SIVD, AD, and CN groups pooled. Using presence or absence of thalamic lacunes as criterion to dichotomize subjects with at least one lacune and accounting for MMSE differences between the groups, we found that thalamic lacunes were associated with 16% lower [NAA] (F ϭ 6.7, df ϭ 2,31, p Ͻ 0.02) in the frontal cortex but not in the parietal cortex figure 2 .
Finally, we tested the extent to which [NAA] measurements added to MRI volume measurements improve differentiation between SIVD and AD. Results are summarized in table 4. Using logistic regression to predict diagnosis, we first entered hippocampal volume into the regression model, because the hippocampus yielded the largest difference of z-scores between patients with SIVD and patients with AD (z ϭ Ϫ1.2 in table 3). The contribution of hippocampal volume in predicting diagnosis was substantial (p ϭ 0.005), achieving an overall classification of 79% with specificity for SIVD of 92%, but sensitivity of only 36%. The area under the ROC curve was 0.83. Adding [NAA] of parietal cortex, which had the second largest z-score difference (Ϫ1.7 vs Ϫ0.9), improved overall correct classification from 79% to 89% (p ϭ 0.02). This was primarily due to an increase for SIVD in sensitivity from 36% to 73% and a slight increase in specificity from 92% to 94%. Consequently, the area under the ROC curve also increased from 0.83 to 0.92. The scatter plot in figure 3 depicts the separation between patients with SIVD and patients with AD with hippocampal volume and [NAA] of parietal cortex. Adding more measures, such as WMH volume, gray matter volume, or frontal lobe cortical [NAA], yielded no further significant improvement. To test separation of patients with SIVD from CN subjects, we first entered cortical gray matter volumes from MRI into the regression model, because this measure had the largest z-score for SIVD (Ϫ1.8 according to table 3). The contribution from gray matter volume in predicting group was significant and yielded for SIVD an overall correct classification of 88% with 55% sensitivity and 96% specificity and an area under the ROC curve of 0. SIVD ϭ subcortical ischemic vascular dementia; AD ϭ Alzheimer's disease; CN ϭ cognitive normal; MRSI ϭ magnetic resonance spectroscopic imaging; AUC-ROC ϭ area under the curve of a receiver operator characteristics analysis.
Discussion.
[NAA] reductions predominantly in frontal and parietal gray matter in patients with SIVD, while sparing white matter and medial temporal lobe, are consistent with findings from several previous MRSI reports on SIVD. [21] [22] [23] [24] However, previous MRSI studies sampled data from only a few, manually selected brain regions and were confounded by gray/white matter partial volumes, potentially introducing a sampling bias. The current study, utilizing all 1 H MRSI voxels in brain slices for analysis and regressing signal variations against voxel tissue composition, obtained metabolite intensities differentially for "pure" gray matter and white matter, greatly reducing complications from partial volume sampling. Therefore, findings from this study establish more firmly than before that cortical [NAA] reductions in SIVD were independent of morphologic brain changes and, furthermore, that regional [NAA] differences between SIVD and AD are not simply a sampling artifact. Although some [NAA] losses in the temporal and parietal cortex in patients with SIVD could be explained by concomitant AD, this does not explain [NAA] losses in the frontal cortex in SIVD, because AD was not associated with [NAA] losses in the frontal brain. Another important finding in SIVD was that [NAA] losses in cortical regions correlated with subcortical infarction load and WMH, implying that subcortical vascular disease was responsible for cortical changes in SIVD. There are several possible explanations for this finding. First, and most likely, is that subcortical infarctions cause functional deafferentation of the cerebral cortex, sometimes termed subcortical-cortical diaschisis. This is consistent with PET studies showing in SIVD hypometabolism and hypoperfusion in cortical regions, 25, 26 especially in the frontal lobe. 27 In support of this view, MRS studies on animals have shown trans-synaptic decrease of NAA levels following acute deafferentation without neuronal loss. 28 It is therefore conceivable that the cortical [NAA] losses in SIVD could indicate deafferented neurons in a state of functional inactivity with a possibility for recovery rather than frank neuron loss. A second explanation is that neurons are damaged or lost via transneuronal degeneration, secondary to subcortical infarctions. 29 With the assumption that [NAA] reflects neuron density, the results imply further that a secondary degeneration causes disproportionately greater loss of neuronal than non-neuronal cells.
A third possibility is that cortical [NAA] reductions are due to cortical ischemia, with or without microinfarctions in the cortex, undetectable with MRI. There are two arguments against this view. First, quite remarkably, we found no [NAA] reduction in white matter in SIVD (or in AD). It would seem reasonable that a widespread ischemic process, which affected cortex and caused subcortical infarctions and WMH, would also produce [NAA] reduction in white matter. Second, [NAA] reductions can occur preferentially in the frontal lobe, as the comparison between subjects with and without thalamic lacunes showed. In presence of a generalized ischemic process, however, one would expect that the entire cortex would be affected, not that the frontal region would be singled out. Eventually, it will be necessary to obtain autopsy information to exclude microinfarctions and concurrent AD as potential cause of cortical [NAA] reduction in SIVD.
The finding of unchanged [NAA] in normalappearing white matter in SIVD, while [NAA] was reduced in the cortex and regions of WMH, is surprising because the predominant disease process in these patients is thought to be subcortical. In another quantitative MRSI study of SIVD, 24 which used analysis of a few voxels of interest, we reported reduced [NAA] of white matter. However, this result was not independent of spurious contributions from [NAA] of WMH in SIVD, which is difficult to correct if only a small number of voxels is sampled. Our finding that the addition of parietal [NAA] to MRI measurements of hippocampal volume improved differentiation between SIVD and AD may be of clinical importance as treatments for the two disorders will be likely different. However, an overlap between the groups remained whether cortical [NAA] and hippocampal volume were used individually or together. Therefore, this will not likely lead to individual patient diagnosis, unless more information is incorporated, such as MRS measurements of myo-inositol 30 or topologic measurements of brain atrophy. [31] [32] [33] A major limitation of this study is that we used clinical and not autopsy data for patient classification, because it is generally recognized that an accurate prediction whether a patient has AD or SIVD is difficult to make antemortem. So far, autopsy data are available from only five patients with AD and three control subjects, but not yet from patients with SIVD. Two of the five autopsied patients were con- firmed AD cases, whereas one had diffuse Lewy body disease and two had mixed AD/SIVD pathology, indicating the complications with accurate antemortem diagnoses. Thus, some patients with SIVD in this study may have had concurrent AD pathology, and some of the patients with AD likely had vascular disease and may have lacked AD pathology. Nevertheless, the finding of a different regional pattern of [NAA] loss in SIVD compared to AD is emphasized by the possibility of such misclassifications, because the ability to distinguish patterns between groups is reduced by misdiagnosis of subjects. There are several other limitations. First, a few patients with AD were taking cholinesterase inhibitors and anticholinergic drugs that could have altered brain metabolite levels, potentially enhancing metabolite differences between AD and SIVD. Secondly, relaxation measurements could not be performed owing to prohibitively long acquisition times. Therefore, [NAA] reduction in SIVD could be due in part to T2/T1 changes rather than to reduced concentration. Finally, detection of cortical atrophy and lacunes was compromised, because tissue segmentation relied on T2-weighted MR images with relatively low resolution (4.2 mm 3 ). It is possible that different results would be obtained if tissue segmentation was performed with higher resolution.
